What is the Share Price of Morepen Laboratories Ltd?

Morepen Laboratories Ltd share price is ₹93.63 As on 15 September, 2024|06:13

Home
>
Stocks
>
Morepen Laboratories Ltd

Morepen Laboratories Ltd

Q: What is the Market Cap of Morepen Laboratories Ltd?

The Market Cap of Morepen Laboratories Ltd is ₹5,130 As on 15 September, 2024|06:13

Q: What is PE Ratio of Morepen Laboratories Ltd?

The P/E ratio of Morepen Laboratories Ltd is 43.6 As on 15 September, 2024|06:13

Q: What is PB Ratio of Morepen Laboratories Ltd?

The PB ratio of Morepen Laboratories Ltd is 5.64 As on 15 September, 2024|06:13

₹ 93.63 -0.41 (-0.44%)
Updated on 14-09-2024 6:56 AM

Stock Rating

Pros 2

Cons 7

Price Performance

Day's Low
₹93.25

Day's High
₹96.1

₹ 93.63

52-w low
₹31.3

52-w high
₹100.9

93.63

Day's open
₹94.42
Previous close
₹94.040001
VWAP
₹94.46
Lower price band
₹74.9
Upper price band
₹112.35

Today's Market Action

The last traded share price of Morepen Laboratories Ltd was 93.63 down by -0.44% on the NSE. Its last traded stock price on BSE was 93.66 down by -0.39%. The total volume of shares on NSE and BSE combined was 11,001,773 shares. Its total combined turnover was Rs 103.92 crores.

Medium and Long Term Market Action

Morepen Laboratories Ltd hit a 52-week high of 100.9 on 10-09-2024 and a 52-week low of 31.3 on 26-10-2023. The stock price of Morepen Laboratories Ltd is up by 54% over the last one month. It is up by 149.68% over the last one year. Don't forget to check the full stock price history in the table below.

Fundamentals

Market Cap (Cr): 5130
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About

Data not available.

FAQ's

What is Share Price of Morepen Laboratories Ltd?

What is the Market Cap of Morepen Laboratories Ltd?

What is PE Ratio of Morepen Laboratories Ltd?

What is PB Ratio of Morepen Laboratories Ltd?

What is the CAGR of Morepen Laboratories Ltd?

How to Buy Morepen Laboratories Ltd Share?

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

Pros

Momentum Strength
The stock is currently exhibiting strong momentum, & is showing consistent strong relative strength.
Zero Debt
The company has almost nil to negligible debt to equity ratio of 0.03. Considering the fact that the business is debt free, equity shareholders shall carry lower risk of holding the stock.

Cons

Low Sustainable RoE
The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
Low Return on Capital Employed
The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
Highly Cyclical Industry
The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
Low Pricing Power & High Competition
The business has extremely low pricing power and is vulnerable to competitive pressure which can significantly impact shareholder returns.
Poor Capital Allocation
The company has disproportionately high amount of assets locked up in working capital, cash and cash equivalents, loans and advances, etc to the extent of 74.25 % of total assets. This reflects poorly on the capital allocation strategy of the management which negatively impacts shareholder returns.
Poor Working Capital Cycle
The company has a very poor working capital cycle of 128 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
Negative Margin of Safety
The relative margin of safety of investing in the company is low due to a recent sharp run up in stock prices.

Valuation Analysis

Margin of safety
(15/09/2024)

Margin of Safety Index: Low

82.06%

82.06% People are bullish about Morepen Laboratories Ltd

17.94%

17.94 % People are bearish about Morepen Laboratories Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %